|
|
|
|
|
|
Home
| Newsroom
| Denagard Topics
|
 |
|
|
|
|
|
|
| No. 8 2005 |
Treatment of Porcine Colonic Spirochaetosis caused by Brachyspira pilosicoli
|
| No. 7 2005 |
Current status of Swine Dysentery in the EU
|
| No. 6 2005 |
Treatment of Actinobacillus pleuropneumoniae (App) infection
|
| No. 5 2005 |
Pharmacokinetics of Denagard® administered via injection or orally
|
| No. 4 2005 |
Haemophilus parasuis (Hp) infections and their control with Denagard®
|
| No. 3 2005 |
Haemophilus parasuis (Hp) infections – epidemiology and role of vaccines in control
|
| No. 2 2005 |
Use of “Denagard®” vs Streptococcus suis (Ss) infections
|
| No. 1 2005 |
Streptococcus suis infection in pigs
|
| No. 9 2004 |
Rationale for the use of “Denagard®” Injectable vs Actinobacillus pleuropneumoniae (App) infection
– clinical experience
|
| No. 8 2004 |
Rationale for the use of “Denagard®” Injectable vs Actinobacillus pleuropneumonia
|
| No. 7 2004 |
Susceptibility of B. hyodysenteriae (B. hyo) to
tiamulin, aivlosin and tylosin in Sweden
|
| No. 6 2004 |
Use of Denagard® for the treatment of the epizootic rabbit enterocolitis (ERE) syndrome
|
| No. 5 2004 |
New sensitivity test results from Professor L. Stipkovits, Hungary reported at IPVS Congress, Hamburg 2004
|
| No. 4 2004 |
New injectable antibiotic for respiratory diseases
of pigs – comparisons with Denagard®
|
| No. 3 2004 |
Research update on the role of M. hyopneumoniae and control methods, including Denagard®/CTC or Doxycycline application
|
| No. 2 2004 |
Global patterns of Porcine Proliferative
Enteropathy (PPE)
|
| No. 1 2004 |
FDA (USA) Guideline document on classification of antibiotics used in veterinary medicine (food animals)
|
|
|
|
|
|
|
|
|
|
|
|
Home
Contact
Help
Legal Disclaimer
Privacy Policy
© 2007 Novartis Animal Health Inc.
Please note that not all products listed within this site may be available in all countries.
Also, prescribing information and indications for products may differ from country to country, so please
consult your local veterinarian for local prescribing and any other information you may be interested in.
|
|
|
